Source Natural Foods & Herbal Supplements Ltd Stock Price Today (NSE: SOURCENTRL)
Source Natural Foods & Herbal Supplements Ltd
Fundamental Score
Source Natural Foods & Herbal Supplements Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Source Natural Foods & Herbal Supplements Ltd share price today is ₹111.00, up +2.07% on NSE/BSE as of 7 August 2026. Source Natural Foods & Herbal Supplements Ltd (SOURCENTRL) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹74.41 (Cr). The 52-week high for SOURCENTRL share price is ₹170.00 and the 52-week low is ₹100.95. At a P/E ratio of 21.88x, SOURCENTRL is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 14.13% and a debt-to-equity ratio of 0.30.
Source Natural Foods & Herbal Supplements Ltd Share Price Chart — NSE/BSE Historical Performance
Source Natural Foods & Herbal Supplements Ltd share price chart: -12.53% return over the past month. 52-week high ₹170.00, 52-week low ₹100.95.
Source Natural Foods & Herbal Supplements Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹128.00 | ₹128.00 | ₹108.00 | ₹108.20 | 9.14K (Cr) | |
| ₹125.00 | ₹125.00 | ₹116.65 | ₹119.85 | 1.54K (Cr) | |
| ₹121.05 | ₹123.00 | ₹117.25 | ₹120.95 | 4.52K (Cr) | |
| ₹133.00 | ₹133.00 | ₹121.00 | ₹121.85 | 6.56K (Cr) | |
| ₹139.95 | ₹139.95 | ₹126.05 | ₹126.65 | 6.52K (Cr) | |
| ₹143.00 | ₹143.00 | ₹126.10 | ₹128.05 | 1.57K (Cr) | |
| ₹148.00 | ₹148.00 | ₹128.05 | ₹129.95 | 978.00 (Cr) | |
| ₹145.00 | ₹145.00 | ₹128.00 | ₹129.95 | 782.00 (Cr) | |
| ₹150.00 | ₹150.00 | ₹126.90 | ₹127.30 | 4.89K (Cr) | |
| ₹151.40 | ₹151.40 | ₹127.50 | ₹128.35 | 4.16K (Cr) |
Source Natural Foods & Herbal Supplements Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹145.00 | ₹148.00 | ₹108.00 | ₹108.20 | -25.38% | |
| ₹109.50 | ₹151.40 | ₹109.50 | ₹127.30 | +16.26% | |
| ₹127.00 | ₹145.00 | ₹100.95 | ₹108.50 | -14.57% | |
| ₹144.70 | ₹145.00 | ₹120.35 | ₹127.00 | -12.23% | |
| ₹143.95 | ₹145.00 | ₹125.25 | ₹138.25 | -3.96% | |
| ₹139.95 | ₹145.00 | ₹121.35 | ₹134.95 | -3.57% | |
| ₹156.10 | ₹156.10 | ₹122.05 | ₹134.55 | -13.81% | |
| ₹144.90 | ₹170.00 | ₹130.00 | ₹144.85 | -0.03% | |
| ₹149.85 | ₹157.95 | ₹132.50 | ₹135.65 | -9.48% | |
| ₹140.50 | ₹155.00 | ₹131.30 | ₹136.35 | -2.95% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Source Natural Foods & Herbal Supplements Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Source Natural Foods & Herbal Supplements Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SOURCENTRL across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Excellent ROCE Performance (17.59%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 21.88 vs Industry: 34.89)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (96.83%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (30.86%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (23.12% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Conservative Debt Levels (D/E: 0.30)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (8.57x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (74.37%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Weak Earnings Growth (0.12% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (0.12% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Source Natural Foods & Herbal Supplements Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Source Natural Foods & Herbal Supplements Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Source Natural Foods & Herbal Supplements LtdSource Natural ...Selected✓ SOURCENTRL • 531398 | 57.8/100 | ₹111.00₹111 | ₹74.41₹74.41 | 21.88Average 21.9 Average | 14.13%Average 14.13% Average | 17.59%Good 17.59% Good | 0.30Excellent 0.3 Excellent | 0.12%Average 0.12% Average | 23.12%Excellent 23.12% Excellent | 0.00% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1990.50₹1991 | ₹468821.49₹468821.49 | 37.73Average 37.7 Average | 15.95%Good 15.95% Good | 20.53%Excellent 20.53% Excellent | 0.06Excellent 0.1 Excellent | 16.75%Excellent 16.75% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 56.3/100 | ₹8056.00₹8056 | ₹193163.97₹193163.97 | 73.64Average 73.6 Average | 16.53%Good 16.53% Good | 21.96%Excellent 21.96% Excellent | 0.00Excellent 0.0 Excellent | 5.71%Good 5.71% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹5122.80₹5123 | ₹169902.02₹169902.02 | 77.52Average 77.5 Average | 27.43%Excellent 27.43% Excellent | 15.19%Good 15.19% Good | 1.79Average 1.8 Average | 12.07%Good 12.07% Good | 11.80%Good 11.80% Good | 0.76% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 40.2/100 | ₹1473.20₹1473 | ₹116131.81₹116131.81 | 30.51Average 30.5 Average | 11.60%Average 11.60% Average | 15.49%Good 15.49% Good | 0.02Excellent 0.0 Excellent | 9.94%Good 9.94% Good | 8.01%Good 8.01% Good | 0.90% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1078.30₹1078 | ₹115375.77₹115375.77 | 21.26Average 21.3 Average | 21.25%Excellent 21.25% Excellent | 21.14%Excellent 21.14% Excellent | 0.46Excellent 0.5 Excellent | 18.77%Excellent 18.77% Excellent | 12.45%Good 12.45% Good | 0.09% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 83.4/100 | ₹2415.00₹2415 | ₹113976.53₹113976.53 | 20.04Average 20.0 Average | 28.68%Excellent 28.68% Excellent | 29.93%Excellent 29.93% Excellent | 0.29Excellent 0.3 Excellent | 37.02%Excellent 37.02% Excellent | 13.02%Good 13.02% Good | 0.72% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2469.60₹2470 | ₹105053.91₹105053.91 | 52.29Average 52.3 Average | 13.12%Average 13.12% Average | 13.50%Average 13.50% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 41/100 | ₹1148.10₹1148 | ₹102660.46₹102660.46 | 25.62Average 25.6 Average | 11.22%Average 11.22% Average | 13.04%Average 13.04% Average | 0.20Excellent 0.2 Excellent | 15.44%Excellent 15.44% Excellent | 12.09%Good 12.09% Good | 0.65% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1580.20₹1580 | ₹90035.87₹90035.87 | 25.38Average 25.4 Average | 10.06%Average 10.06% Average | 12.80%Average 12.80% Average | 0.21Excellent 0.2 Excellent | 0.80%Average 0.80% Average | 6.32%Good 6.32% Good | 0.26% |
Laurus Labs LtdLaurus Labs Ltd... LAURUSLABS • 540222 | 34.1/100 | ₹1816.20₹1816 | ₹84016.75₹84016.75 | 93.94Average 93.9 Average | 18.30%Good 18.30% Good | 17.76%Good 17.76% Good | 0.48Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price468821.49 Cr
- Divis Laboratories Ltd share price193163.97 Cr
- Torrent Pharmaceuticals Ltd share price169902.02 Cr
- Cipla Ltd share price116131.81 Cr
- Zydus Lifesciences Ltd share price115375.77 Cr
Source Natural Foods & Herbal Supplements Ltd Quarterly Performance
Latest quarterly metrics for SOURCENTRL — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
30.86%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
96.83%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
23.12%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
0.12%
Compounded annual net profit growth over 5 years
Source Natural Foods & Herbal Supplements Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SOURCENTRL — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
Source Natural Foods & Herbal Supplements Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Source Natural Foods & Herbal Supplements Ltd (SOURCENTRL) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Source Natural Foods & Herbal Supplements Ltd
About SOURCENTRL (Source Natural Foods & Herbal Supplements Ltd)
Source Natural Foods & Herbal Supplements Ltd is a dynamic force in the Indian pharmaceutical landscape, dedicated to harnessing the power of nature to promote holistic well-being.... Rooted in the ancient wisdom of Ayurveda, the company meticulously crafts a comprehensive portfolio of health and dietary supplements designed to address a wide spectrum of health needs. From revitalizing beverages to potent single herb formulations, Source Natural Foods & Herbal Supplements seeks to provide accessible and effective solutions for individuals seeking to enhance their health naturally. The company's commitment to quality and innovation is evident in its diverse product line, carefully formulated to support a balanced and healthy lifestyle. Central to Source Natural Foods & Herbal Supplements' philosophy is the belief that targeted nutritional support can significantly impact overall health. The company's offerings encompass a broad range of healthcare products, catering to specific needs such as orthopedic support, diabetes management, digestive health, respiratory wellness, and skincare. Recognizing the importance of addressing modern health challenges, Source Natural Foods & Herbal Supplements also provides specialized formulations for heart health, liver and kidney care, pain relief, and weight management. Furthermore, the company emphasizes the significance of mental wellness and immune support, offering products designed to promote cognitive function, reduce stress, and strengthen the body's natural defenses. Driven by a passion for natural health solutions, Source Natural Foods & Herbal Supplements extends its expertise to address specialized areas of well-being. The company's product line includes natural vitamins and supplements designed to fill nutritional gaps, as well as targeted solutions for ophthalmic and ENT care. Recognizing the unique health needs of women, Source Natural Foods & Herbal Supplements offers a range of products tailored to support women's wellness at every stage of life. With a steadfast commitment to quality, innovation, and customer satisfaction, Source Natural Foods & Herbal Supplements strives to be a trusted partner in promoting health and vitality through the power of nature.
Company Details
Key Leadership
Corporate Events
SOURCENTRL Share Price: Frequently Asked Questions
What is the current share price of Source Natural Foods & Herbal Supplements Ltd?
Source Natural Foods & Herbal Supplements Ltd (SOURCENTRL) trades at ₹111.00 on NSE and BSE. Market cap ₹74.41 (Cr). Educational data only.
What is the P/E ratio of Source Natural Foods & Herbal Supplements Ltd?
Source Natural Foods & Herbal Supplements Ltd has a P/E of 21.88x vs industry average 34.89x.
What is the Bull Run score for Source Natural Foods & Herbal Supplements Ltd?
Source Natural Foods & Herbal Supplements Ltd has a Bull Run score of 57.8/100 based on 25+ financial parameters.
Does Source Natural Foods & Herbal Supplements Ltd pay dividends?
Source Natural Foods & Herbal Supplements Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Source Natural Foods & Herbal Supplements Ltd?
Source Natural Foods & Herbal Supplements Ltd has ROE of 14.13%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Source Natural Foods & Herbal Supplements Ltd?
Source Natural Foods & Herbal Supplements Ltd has debt-to-equity of 0.30.
Is Source Natural Foods & Herbal Supplements Ltd a good investment?
Bull Run gives Source Natural Foods & Herbal Supplements Ltd a score of 57.8/100. This is not investment advice — consult a SEBI-registered advisor.